On July 08, 2025, the new drug application (NDA) of the innovative drug Rademikibart, jointly developed by the Simcere（2096.HK） and Connect Biopharma,...
On June 20, 2025, Simcere Pharmaceutical (2096.HK) announced that QUVIVIQ® (generic name: Daridorexant Hydrochloride Tablets), an anti-insomni...
Shanghai, China, June 18, 2025 — Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK) today announc...
- NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights- ...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions